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Minnesota Academic Health Center, Minneapolis, MinnesotaABSTRACT Troponin I (TnI) is the molecular switch of the sarcomere. Cardiac myocytes express two isoforms of TnI during
development. The fetal heart expresses the slow skeletal TnI (ssTnI) isoform and shortly after birth ssTnI is completely and irre-
versibly replaced by the adult cardiac TnI (cTnI) isoform. These two isoforms have important functional differences; broadly,
ssTnI is a positive inotrope, especially under acidic/hypoxic conditions, whereas cTnI facilitates faster relaxation performance.
Evolutionary directed changes in cTnI sequence suggest cTnI evolved to favor relaxation performance in the mammalian heart.
To investigate the mechanism, we focused on several notable TnI isoform and trans-species-specific residues located in TnI’s
helix 4 using structure/function and molecular dynamics analyses. Gene transduction of adult cardiac myocytes by cTnIs with
specific helix 4 ssTnI substitutions, Q157R/A164H/E166V/H173N (QAEH), and A164H/H173N (AH), were investigated. cTnI
QAEH is similar in these four residues to ssTnI and nonmammalian chordate cTnIs, whereas cTnI AH is similar to fish cTnI
in these four residues. In comparison to mammalian cTnI, cTnI QAEH and cTnI AH showed increased contractility and slowed
relaxation, which functionally mimicked ssTnI expressing myocytes. cTnI QAEH molecular dynamics simulations demonstrated
altered intermolecular interactions between TnI helix 4 and cTnC helix A, specifically revealing a new, to our knowledge, elec-
trostatic interaction between R171of cTnI and E15 of cTnC, which structurally phenocopied the ssTnI conformation. Free energy
perturbation calculation of cTnC Ca2þ binding for these conformations showed relative increased calcium binding for cTnI QAEH
compared to cTnI. Taken together, to our knowledge, these new findings provide evidence that the evolutionary-directed coor-
dinated acquisition of residues Q157, A164, E166, H173 facilitate enhanced relaxation performance in mammalian adult cardiac
myocytes.INTRODUCTIONCardiac contractility is a fine-tuned process of allosteric
regulation by Ca2þ activation of thin and thick myofilament
interaction and force production. The heterotrimeric
troponin complex is the key regulator in contractility,
sensing Ca2þ and subsequently regulating myosin inter-
action with actin (1,2). Alterations in troponin affinity for
Ca2þ due to isoform switching, biochemical milieu, or hu-
man mutations dramatically alter troponin and heart per-
formance (3). Understanding the mechanism of troponin
function is therefore critical to ultimately developing strate-
gies that redress pathogenic alterations in contractility.
Cardiac troponin is composed of troponin C (cTnC), the
Ca2þ sensitive subunit, troponin I (cTnI), the inhibitory
subunit, and troponin T (cTnT), the tropomyosin binding
subunit. Upon excitation of cardiac myocytes, Ca2þ is
released from the sarcoplasmic reticulum, resulting in a
rapid and marked increase in intracellular Ca2þ. Cardiac
TnC binds Ca2þ to partially open the N-terminal hydropho-
bic pocket and allow the switch region of cTnI (~residues
147–163) to then interact and fully open this hydrophobic
pocket of cTnC (4). Interaction of the cTnI switch peptide
region with cTnC is modeled to pull the cTnI inhibitory re-
gion (~residues 128–146) and mobile domain (~residuesSubmitted January 2, 2014, and accepted for publication April 4, 2014.
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0006-3495/14/05/2105/10 $2.00172–210) away from actin, resulting in movement of tropo-
myosin and revealing myosin strong binding sites on actin
(5). Release of Ca2þ from cTnC and the subsequent disen-
gagement of cTnI allows the inhibitory region and mobile
domain of cTnI to again strongly interact with actin to
inhibit myosin strong binding and thus initiate relaxation.
The dynamic Ca2þ-dependent interchange between cTnI
and cTnC/actin makes cTnI the molecular switch of the
sarcomere.
In mammalian cardiac development, two TnI isoforms
are sequentially expressed, ssTnI (TNNI1), the neonatal iso-
form, and cTnI (TNNI3), the adult isoform. In the first
20 days after birth in rodents and in newborn humans, a
complete and irreversible stoichiometric shift from ssTnI
to the cTnI isoform occurs in the cardiac sarcomere (6,7);
experimentally blocking this transition by the transgenic
expression of ssTnI in adult mice results in diastolic
dysfunction (8). In terms of cardiac function, ssTnI and
cTnI show three main biophysical differences: 1), ssTnI
shows increased Ca2þ sensitivity under physiologic condi-
tions; 2), ssTnI shows marked resiliency to ischemia/
acidosis-mediated Ca2þ desensitization of the thin filament;
and 3), cTnI has a unique 32 amino acid N-terminal exten-
sion necessary for PKA-regulated Ca2þ desensitization of
the thin filament required to hasten relaxation performance
(9,10). These functional differences along with the highly
regulated and nonreversible developmental TnI isoformhttp://dx.doi.org/10.1016/j.bpj.2014.04.017
2106 Thompson et al.switch suggest that mammalian cTnI has evolved to favor
enhanced relaxation performance over preserved inotropy
in ischemia/acidosis.
Phylogenetic analysis of TnI through chordate evolution
reveals that the amphibian and avian cTnI isoform is more
similar to mammalian ssTnI than to mammalian cTnI
(11). This difference is highly notable in the switch/helix
4 region of cTnI, the region that interacts with cTnC during
Ca2þ binding. Four amino acid charge changes in mamma-
lian cTnI compared to other chordate TnIs (either cTnI
or ssTnI) are evident in this analysis: Q157R, A164H,
E166V, and H173N (mammalian cTnI to ssTnI residues,
respectively). Based on this analysis, we proposed a model
whereby a key histidine to alanine transition at position 164
was evolutionarily selected for enhanced relaxation perfor-
mance in the endothermic adult heart (11). A single histi-
dine residue in ssTnI (H132) is responsible for the marked
resistance to pH-dependent desensitization (12,13). Substi-
tution of cognate residue A164 with histidine in cTnI results
in marked protection from ischemia/acidosis-mediated
Ca2þ desensitization in vitro and in vivo (13–16). Mechanis-
tically, this histidine is hypothesized to be protonated under
acidic conditions to then interact with E19 of cTnC
increasing affinity of ssTnI for cTnC (11,17). Further
evidence from molecular dynamics (MD) simulations and
NMR suggest that this electrostatic interaction also occurs
in cTnI A164H (18,19). Taken together, these studies
support the necessity of histidine 132(ssTnI)/164(cTnI) in
conferring resistance to Ca2þ desensitization in acidic con-
ditions through its interaction with E19 of cTnC (11,17–19).
Although cTnI A164H mimics ssTnI resistance to Ca2þ
desensitization in acidic conditions, it differs from ssTnI
in two ways. First, cTnI A164H has the N-terminal exten-
sion that contains the two critical PKA sites for increased
relaxation performance during adrenergic stimulation (20).
Second, cTnI A164H shows little to no alteration in Ca2þ
sensitivity compared to wild-type (WT) cTnI at neutral pH
(13). Earlier work showed that ssTnI H132A functionally
mimicked cTnI, showing that ssTnI H132 imparts pH resis-
tance while retaining ssTnI baseline pH Ca2þ sensitivity
(12). Because cTnI A164H does not have significant
increased Ca2þ sensitivity (like ssTnI) at baseline, other
TnI isoform-specific residues must impart heightened base-
line Ca2þ sensitivity to ssTnI. Stated differently, it is unclear
why cTnI A164H confers selected Ca2þ sensitivity enhance-
ment at acidic pH and not at neutral pH distinguishing it
from ssTnI function. Dargis and colleagues (16) showed
in thin filament regulated myosin ATPase activity assays
that the ssTnI isoform substitutions Q157R/A164H/E166V
in cTnI cause apparent increased Ca2þ sensitivity, whereas
Q157R/E166V cTnI showed no increased Ca2þ sensitivity
compared to cTnI. This suggests that a specific histidine
(cTnI A164H) is necessary for increased Ca2þ sensitivity
but only in the context of other, yet to be defined TnI iso-
form-specific residues (16).Biophysical Journal 106(10) 2105–2114A central aim of this study is to dissect TnI residues key
for enabling cardiac contractile performance in health and
disease. To gain mechanistic insight into Ca2þ desensiti-
zation of cTnI compared to ssTnI, we determine here the
importance of the evolutionary conserved isoform-specific
residues Q157, A164, E166, and H173 of cTnI. Functional
analysis in adult cardiac myocytes paired with MD simula-
tions and free energy perturbation analysis of cTnI Q157R/
A164H/E166V/H173N (QAEH) establishes a basis for
increased TnI-TnC interaction resulting in increased
contractility. Based on these new, to our knowledge, findings
we propose that two salt bridges between cTnI QAEH and
cTnC alter Ca2þ binding to cTnC and therefore increase
contractility and slow relaxation. These findings will be use-
ful in informing future gene, cell, and small molecule-based
strategies to enhance cardiac contractility in disease.METHODS
Generation of cTnI isoform substitutions and viral
vector construction
We used a pGEM3Z vector containing cTnI-Flag, A164H cTnI-flag,
A164H/E166V cTnI-flag, and Q157R/A164H/E166V cTnI-flag, and the
QuikChange mutagenesis kit (Stratagene, LaJolla, CA) to generate site-
directed mutants according to the manufacturer’s protocol. Primers used
for mutagenesis for Q157R: sense 50- GCA GAT GCC ATG ATG CGG
GCA CTA CTG GGG ACC -30, antisense 50- GGT CCC CAG TAG TGC
CCG CAT CAT GGC ATC TGC -30 for H173N: sense 50- CCT TGG
ACC TGA GGG CCA ACC TCA AGC AGG TGA AG -30, antisense 50-
CTT CAC CTG CTT GAG GTT GGC CCT CAG GTC CAA GG -30.
Mutated DNA was sequenced before subcloning of mutant cTnI cDNA
into pDC315 adenovirus shuttle vector. All DNA sequences were verified
by overlapping sequence runs. Recombinant Ad5 adenoviruses were pro-
duced and purified as described previously (21). Adenoviruses for ssTnI,
cTnI-flag, and A164H cTnI-flag were generated previously (9,13) and
used as controls here.
Ventricular myocyte isolation, gene transfer, primary culture, immuno-
blot, indirect immunofluorescence, and contractility were performed as pre-
viously described (22,23) and detailed in the Supporting Material.MD simulations
The simulations were conducted as previously described (19). Briefly, the
starting structures were obtained from Protein Data Bank (PDB) 1J1E
chains D and F for cTnC (residues 1–90) and cTnI (residues 148–174),
respectively. For sTnI (residues115–140) PDB 1YTZ was used and sTnI
was modeled onto cTnC. Missing amino acids G50 and Q51 of cTnC
and missing hydrogen atoms were added and energy minimized using
OPLS 2005 force field (24). The imidazole groups of all histidines in the
structure were ionized according to the calculated pKas. All simulations
were carried out using NAMD version 2.6 with CHARMM27 protein
force field and TIP3P water model (25). Each protein complex was solvated
in a rectangular box with a 15 A˚water buffer from the protein. Naþ and Cl
counter ions were added at 5 A˚ from the box boundary to neutralize the
total charge of the system. Each system was initialized by a 5000 steps
conjugate gradient energy minimization with protein heavy atoms
restrained at 50 kcal/(molA˚2). The restraint system was gradually heated
from 25 to 300 K at 25 K increments at every 10 ps interval for 100 ps
followed by a 100 ps equilibration with gradual removal of the heavy
atoms restraint at 10 ps interval under a NVT condition. The final
Troponin I and Myocyte Relaxation 2107unrestrained equilibration was carried out for 100 ps followed by 40 ns of
production simulation at 1 atm and 300 K NPT condition. The simulations
were carried out under a periodic boundary condition using particle mesh
Ewald (26). The SHAKE (27) method was employed to restrain all
hydrogen bonds. A 2 fs time step was used with coordinates saved at
1 ps time intervals, resulting in a total of 40,000 configurations for simula-
tion. Three to five 40 ns simulations were carried out for each of the
modeled complexes by random initialization of the starting velocities.
These simulations were conducted using computational resources from
the University of Minnesota Supercomputing Institute.Interatomic distance calculations
All distances were evaluated in angstrom units over the entire 40 ns of the
simulation. For the cTnI QAEH HSD and cTnI QAEH HSP simulations of
the cTnI:cTnC complex and the sTnI of the sTnI:cTnC complex, the
average distance was evaluated between cTnI H164 (NE2) or sTnI H132
(NE2) and cTnC E19 (OE2). Distance measurements for the WT structure
were taken between cTnI A164 (CB) or sTnI A132 (CB), respectively, and
cTnC E19 (OE2).Other distance analysis was done for all the simulations
between cTnI R171 (NH2) and cTnC E15 (OE2), between cTnC E40
(OE2) and cTnC K39 (NZ) and cTnC K43 (NZ).Theoretical pKa calculations
The pKa was carried out as previously described (19,28). Briefly, the protein
pKa of ionizable residue, pK
p
a , is evaluated by
pKpa ðAHÞ ¼ pKwa ðAHÞ þ
1
2:303RT
DDGw/pself

AH/A

:
(1)
Here, pKwa is the model pKa of the amino acid side chain in water. The
electrostatic contribution toward the self-free energy,DDGw/pself was
obtained by evaluating the average electrostatic potential based on the nu-
merical solution to the linearized Poisson-Boltzmann equation
V , εðrÞVfðrÞ  k2εðrÞfðrÞ ¼ 4pr0ðrÞ; (2)
where ε(r) is the distance dependent dielectric constant, f(r) is the electro-
static potential at point r, r0 ðrÞ is the permanent charge density of the solute
and k is inverse Debye-Huckle salt screening length. The electrostatic
contribution toward the changes in the change in the self-free energy,
DDGw/pself , of a given residue, i, can be described by
DDGw/pself;i ¼ DDGw/pborn þ DGpback þ
Xn
j
qiqjWij; (3)
where DGpback is the interaction between the ionized group with the protein
permanent dipoles and DDGw/pborn is free energy of desolvation of moving
the group from water to the protein.
These first two terms account for the free energies associated with
moving the indicated ionizable group in its neutral (AH) and ionized
(A) state from water to the protein when all other groups are in their
uncharged state and the latter term,
Pn
j qiqjWij , account for the charge-
charge interaction among all ionizable groups inside the protein. The pro-
tein pKa, therefore, is given by
pKpa ¼ pKinta þ DpKchargesa ; (4)
where pKinta is the intrinsic pKa of the ionizable residue inside the protein
when all other ionizable groups are in their neutral states and DpKchargesa
represents the pKa shifts due to the charge-charge interaction between
the indicated titratable group with all other ionized groups in their averageionization states in the protein. This methodology allows for a straight-
forward decomposition of the total computed pKa value as the sum of the
effects due to the change in moving the ionized group from water to the
polar environment of the protein when all ionizable groups are set to their
neutral state ðpKinta Þ and its interaction with all other ionizable groups
ðDpKchargesa Þ. Thus, the calculated pKa values can be used to characterize
the strength of electrostatic interactions between neighboring groups in
protein.
In this work the calculations were carried out based on the web-based
implementation of the linearized Poisson-Boltzmann implicit solvent
model available via Hþþ server (29). A protein dielectric constant of 4
and 40 was used for the intrinsic pKa calculation and the DpK
charges
a ,
respectively. Three independent frames from three simulations were used
to calculate the average pKa measures shown in Table S1.These frames
were stable conformations and spaced equally throughout the simulations
at 20, 30, and 40 ns. Hþþ does not allow pKa values to exceed 12,
therefore, arginine DpKchargesa are not a true representation of electrostatic
interaction strength.Free energy perturbation calculation
The relative binding free energy of the Ca2þ ion between the WT and its
mutant DDGwild/mutbind was evaluated using the free energy perturbation
(FEP) method that has been used previously for the studies of charges in
solution (30,31) and proteins (32). The binding free energy, DG, associated
for ionizing a charge within its water or protein-water environment involves
the adiabatic charging process where the charge (Q) of the Ca2þ ion is grad-
ually changed from Q ¼ 0/ Q ¼ Q0 where Q0 ¼ þ2 for Ca2þ ion. The
free energy is given by
DGðQ ¼ 0/Q ¼ Q0Þ ¼
XN1
m¼ 0dGðlm/lmþ1Þ
dGðlm/lmþ1Þ ¼ b1 ln<exp½  bðεmþ1  εmÞ>εm;
εm ¼ ð1 lmÞεðQ ¼ 0Þ þ lmεðQ ¼ Q0Þ
(5)
where εm is the mapping potential and lm is the mapping parameter. The
complete charging process involves 11 mapping steps with each mapping
step performed at 300 K for 20 ps with a step size of 1 fs. To prevent the
diffusion of the Ca2þ ion from the binding pocket when its charge is grad-
ually changed to zero, a harmonic restraint of 200 kcal/mol A˚2 was applied
to restrain the nearby chelating residues (Asp-65, Asp-67, Asp-73 and Glu-
76, and Ser-69) to crystallography observed Ca2þ ion position and dis-
tances. Four independent frames from 10 to 40 ns were analyzed for each
simulation on the 3–5 simulations run per variant. The relative association
binding free energy was then evaluated by the difference between the WT
and its mutant. The FEP calculations were conducted within the Molaris
9.09 software modeling package (33).Statistics
All results are expressed as mean 5 SE. Multigroup comparisons were
assessed using one-way analysis of variance with the Bonnferoni post-
hoc test with P < 0.05 considered statistically different.RESULTS
Replacement and incorporation of cTnI
substitutions by gene delivery
To determine the structure-function relationship of the iso-
form-specific residue substitutions between cTnI and ssTnI,Biophysical Journal 106(10) 2105–2114
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FIGURE 2 Replacement and incorporation of the adenoviral transduced
adult cardiac myocytes. (A) RepresentativeWestern blot of adult rat ventric-
ular myocytes day 3 after transduction probed with a pan-TnI antibody.
Flag-cTnI, endogenous cTnI and ssTnI labels denote expected sizes for
each isoform. All cTnI isoforms are Flag tagged. (B) Quantification of
TnI replacement based on Western blot comparing exogenous (Flag
band) to total TnI (n ¼ 9–12 for each group from 3 to 4 independent exper-
iments). (C) Indirect immunofluorescence of FLAG-tagged substitutions
showing normal sarcomeric staining. Measurement bar ¼ 10 mm. Inset
shows normal thin filament staining for the two substitutions cTnI
AH and cTnI QAEH compared to WT cTnI. To see this figure in color,
go online.
2108 Thompson et al.we used in vitro cellular methods. Recombinant adenovi-
ruses were generated to express the cTnI to ssTnI sub-
stitutions as shown in Fig. 1. The four isoform-specific
residues are highlighted and denote residues that change
significantly during chordate evolution (11,34). This study
is aimed at identifying the impact of these isoform-specific
residues through substitution of ssTnI residues, Q157R,
A164H, E166V, and H173N in the context of the mamma-
lian cTnI template.
To study the effects of the cTnI substitutions in vitro,
adult rat cardiac myocytes were transduced with re-
combinant adenoviral vectors encoding the cTnI to ssTnI
substitutions Q157R/A164H/E166V/H173N (QAEH) or
A164H/H173N (AH). This system approaches 100%
efficiency for myocyte transduction and takes advantage
of the well-documented stoichiometric replacement of
endogenous TnI (9,23,35,36). All cTnI substitutions
were Flag-tagged to track the modified TnIs through differ-
ential migration in SDS-PAGE compared to the endo-
genous and through immunofluorescence for analysis
of incorporation into the sarcomere. We showed previously
that this epitope does not alter function (12,19,23,36).
Three days after transduction cardiac myocytes were
harvested for expression and replacement studies via
Western blot and indirect immunofluorescence for detec-
tion of incorporation into the thin filament. As has been
well documented (9,19,23,37), cTnI gene transfer showed
stoichiometric replacement of the endogenous protein
with the cTnI-Flag substitutions or the ssTnI. Fig. 2 A
shows that the endogenous cTnI band decreases as the
cTnI-Flag band incorporates into the sarcomere. The
Western blots were quantified using Odyssey analysis
to determine the extent of replacement. All the TnI sub-
stitutions showed 70–80% stoichiometric replacement as
shown in Fig. 2 B. Sarcomeric incorporation of these
cTnI substitutions was determined via indirect immuno-
fluorescence through the Flag epitope. Fig. 2 C shows
that the cTnI substitutions have a sarcomeric staining
pattern consistent with proper incorporation into the thin
filament.ssTnI M  L  R  A L L G S K  H K  V S M D L R A N
cTnI M M Q A L L G T R  A  K  E  S L D L R A H
cTnI A164H    M M Q A L L G T R  H  K  E  S L D L R A H
 cTnI QAEH     M M R  A L L G T R  H  K  V  S L  D L R A  N
160 170
cTnI AH M M Q A L L G T R   H  K  E  S L DL R A N
“ssTnI like”
“Fish cTnI like”
N-term ext  TnC binding IT-arm IR Switch arm Mobile domain TnI
FIGURE 1 Troponin I isoform sequence alignment highlighting the sub-
stitutions used in this study. Top bar depicts the domains of cTnI showing
the sequence region of the switch arm and a portion of the mobile domain.
Differences between cTnI and ssTnI boxed in red. Substitutions from cTnI
to ssTnI are marked in red for the ssTnI amino acid. To see this figure in
color, go online.
Biophysical Journal 106(10) 2105–2114Sarcomere dynamics in living cells under
physiologic and acidic pH conditions
Sarcomere length dynamics in single adult rat cardiac
myocytes transduced with cTnI substitutions were con-
ducted to ascertain the functional impact of these substitu-
tions at pH 7.4 and pH 6.2. All studies were conducted on
day 3 after gene transfer. The cTnI substitutions QAEH
and AH were compared to cTnI, cTnI A164H, and ssTnI
(Fig. 3). Fractional shortening %, is a measure of contrac-
tility and shows that ssTnI, cTnI QAEH, and cTnI AH
have heightened contractility, whereas cTnI A164H
shows normal contractility under physiologic conditions
(Fig. 3 C). As a measure of relaxation, time to baseline
50% shows that cTnI QAEH and cTnI AH have slowed
relaxation (Fig. 3 D). Taken together these data are consis-
tent with cTnI QAEH and cTnI AH as Ca2þ sensitive substi-
tutions, much like ssTnI, and functionally resemble ssTnI
more than either cTnI or cTnI A164H.
We previously showed that cTnI A164H and ssTnI pre-
serve contractile function under acidic conditions compared
to cTnI (9,13,19). To determine the impact of cTnI
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FIGURE 3 Sarcomere length dynamics at physiologic pH and in
acidosis. (A) Representative traces of sarcomere length dynamics normal-
ized to baseline of the five groups (Black ¼ pH 7.4, White ¼ pH 6.2).
(B–D) pH 7.4 sarcomere length dynamics showing baseline sarcomere
length, fractional shortening, and the relaxation parameter time from
peak amplitude to 50% baseline. (E and F) pH 6.2 sarcomere length dy-
namics showing baseline sarcomere length and fractional shortening. (G)
The change in fractional shortening from pH 6.2 to pH 7.4. n ¼ 45–60 my-
ocytes from six independent experiments for each group. *P < 0.05 from
one-way analysis of variance with the Bonferroni post hoc test.
FIGURE 4 (A) Atomistic ribbon structure representations of the starting
structures used for simulation. cTnI starting structure was the same for all
cTnI variants. (B) Atomistic ribbon structure representations of the 40 ns
frame from TnC-TnI MD simulations. Red is cTnC 1–90, Blue is cTnI
148–174 or sTnI 115–140, yellow shows the position of the QAEH residues
that have been substituted with the ssTnI residue. HSP (histidine proton-
ated), HSD (histidine deprotonated). Atomistic stick figure represents the
cTnC helix A (red) position in relation to the TnI switch peptide-helix 4
position (blue). To see this figure in color, go online.
Troponin I and Myocyte Relaxation 2109substitutions on contractile function in acidosis, we tested
sarcomere length dynamics at pH 6.2. Consistent with pre-
vious publications (9,13,19), cTnI A164H and ssTnI main-
tain fractional shortening at pH 6.2 compared to cTnI
(Fig. 3 F). cTnI QAEH and cTnI AH showed similar frac-
tional shortening in acidic conditions to cTnI A164H and
ssTnI. The change in fractional shortening between pH 7.4
and pH 6.2 was calculated to determine if each substitution
preserved contractile function in acidosis. Fig. 3 G shows
that only cTnI A164H and ssTnI have delta fractional short-
ening that is not statistically different from 0% indicating
that these TnI constructs preserve contractile function in
acidosis. Although cTnI QAEH and cTnI AH have similar
pH 6.2 fractional shortening to cTnI A164H and ssTnI,
they show delta fractional shortening values that are similar
to cTnI. This suggests that they are baseline Ca2þ sensitizersand are not pH titratable molecular inotropes as found in
cTnI A164H.MD simulations
To gain structural insight into the mechanism of modified
cTnI function we performed MD simulations. Simulations
were carried out with sTnI-cTnC, cTnI-cTnC, and cTnI
QAEH-cTnC in both the histidine protonated (HSP) and
deprotonated state (HSD). Starting structures were truncated
cTnC residues 1–90 and cTnI residues 148–174 from the
Ca2þ bound human cTn crystal structure (PDB, 1J1E,
chains D and F) (38), and sTnI 115–140 from the Ca2þ
bound chicken fast-skeletal troponin crystal structure
(PDB, 1YTZ) (39) and mutated computationally. We used
chicken fast-skeletal TnI as a surrogate for ssTnI, as these
two proteins do not differ in the sequence region of interest
(11). Three simulations were run with different starting
velocities for each molecule over 40 ns to probe conforma-
tional space. Representative structures at 40 ns show major
conformational differences between sTnI and cTnI (Fig. 4).
The switch region in all simulations is generally in the same
position and making the same contacts. The C-terminal half
in sTnI, helix 4, is unstructured and bends to interact withBiophysical Journal 106(10) 2105–2114
2110 Thompson et al.cTnC helix A (Fig. 4 B), whereas in cTnI helix 4 is not in-
teracting with cTnC (Fig. 4 B). Substitutions that make cTnI
more ssTnI-like in function, cTnI QAEH, show a similar
overall conformation as sTnI with a bend of helix 4 and
closer proximity to cTnC helix A, only when the histidine
is protonated to mimic acidosis (HSP) (Fig. 4 B).cTnI QAEH HSP helix 4 interactions
Previous work provided evidence that in the protonated state
cTnI A164H and residue H132 of sTnI interact with E19 of
cTnC (17,19). In this study,MD analysis of cTnI QAEHHSP
showedH164 in close proximity to cTnC E19 throughout the
40 ns simulation for two of the three simulations (Fig. 5 A).
Average DpKchargesa as a measure of shift in pKa due to elec-
trostatic interactions showed cTnC E19 - cTnI QAEH HSP
has strong electrostatic interactions (1.22) comparable to
sTnI (1.41). The electrostatic interaction for cTnI H164E15
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FIGURE 5 Ribbon structures of TnI Helix 4 interactions with cTnC. (A)
Representative frame of QAEH cTnI 3 HSP showing H164 of TnI interac-
tion with E19 of cTnC, cTnC Red, cTnI blue. Inset shows distances between
E19 and H164. (B) Representative distance trace from H164 to E19
comparing one simulation from WT cTnI (black), sTnI (green), and
QAEH cTnI (blue). (C) Average distance over the entire 40 ns error bars
are þ/ SE. (D) Representative frame of QAEH cTnI 3 HSP showing
R171of cTnI interaction with E15 of cTnC, cTnC Red, cTnI blue. Inset
shows distance between E15 and R171. (E) Representative distance trace
from R171 to E15 comparing one simulation from WT cTnI (black) and
QAEH cTnI (blue). (F) Average distance over the entire 40 ns, error bars
are þ/ SE. To see this figure in color, go online.
Biophysical Journal 106(10) 2105–2114was less (0.30) but was considerably different than cTnI
QAEH HSD (0.35) where this interaction did not occur
(Table S1). This histidine to glutamic acid electrostatic inter-
action has been suggested to be the mechanism of main-
tained contractile function under acidic conditions when
histidine would be protonated. Further analysis of the simu-
lations revealed that cTnI QAEHHSP has additional interac-
tions of cTnI helix 4 with cTnC. A key new interaction found
here was R171 of cTnI as it is within 3 A˚ of E15 of cTnC in
two out of three simulations (Fig. 5 D). These are the same
two simulations that showed H164-E19 interaction. pKa
analysis showed strong electrostatic interactions with cTnC
E15 (1.26) with cTnI QAEH HSP, although this residue
has no apparent electrostatic interactions in cTnI WT or
cTnI QAEH HSD (Table S1). Hþþ does not allow values
to be >12, therefore, arginines do not show any DpKchargesa
and are not included in this analysis. This further interaction
of helix 4 is similar to sTnI, which has many side chains
within 3 A˚ of cTnC side chains in this region of the protein.
In contrast, cTnI A164H simulations published by Palpant
et al. (19) showed the cTnI H164-cTnC E19 interaction but
no further interactions in helix 4.QAEH HSD cTnI alters cTnC intramolecular
interactions
The deprotonated cTnI QAEH (HSD) showed an overall
structure similar to cTnI. The switch region is tilted slightly
but no overall gross conformational changes were observed.
Analysis of pKa measurements revealed an electrostatic
interaction in cTnC E40-K39 in the cTnI WT, simulations
that shift to E40-K43 in the sTnI, cTnI QAEH HSP, and
cTnI QAEH HSD (Table S1). Distance measurements
across the entire 40 ns simulations showed this shift in
TnC intramolecular interaction is stable throughout the
simulations (Fig. 6). We speculate this shift may alter
further interactions through helix C and site I of cTnC and
therefore affect site II Ca2þ binding (40,41).Free energy of cTnC Ca2D binding
To investigate if the conformations obtained throughout the
simulations affect Ca2þ binding affinity, we performed FEP
calculations on sample frames from 10 to 40 ns for all iso-
forms. Distance constraints were put on the cTnC site II
Ca2þ chelating residues Asp-65, Asp-67, Asp-73, Glu-76,
and Ser-69, whereas the charge of the Ca2þ ion was gradu-
ally changed from 0 to þ2. The binding free energy was
averaged over the multiple simulations snapshots for the
given isoform. The relative free energy of Ca2þ binding is
shown in Fig. 7. This analysis showed decreased Ca2þ
binding free energy for both cTnI QAEH HSD and HSP
relative to cTnI, consistent with the proposition that these
conformations seen throughout the simulation could facili-
tate increased Ca2þ binding affinity. We further performed
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FIGURE 6 MD-derived intramolecular analysis of E40 cTnC distance
measurements to cTnC residues K39 and K43. Black trace is E40-K39,
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histidines). To see this figure in color, go online.
Troponin I and Myocyte Relaxation 2111FEP on the previously published simulations for cTnI
A164H HSD and HSP (19). Here, cTnI A164H HSD
showed no difference to WT cTnI, whereas cTnI A164H
HSP showed marked decreased free energy of Ca2þ binding.
These findings are consistent with the cellular data shown
here where A164H cTnI has no neutral pH effect while pre-
serving contractility in acidosis (Fig. 3).cTnI
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FIGURE 7 Relative Ca2þ binding free energy. The change in Ca2þ bind-
ing free energy normalized to the average of WT cTnI plotted as,
DDGwild/mutbind . Four representative frames from all simulations for a given
isoform were calculated and averaged, error bars are þ/ SE. *p < 0.05
from a Student’s t-test to cTnI value.contractility. The combination of sarcomere length dy-
namics in living adult cardiac myocytes together with
state-of-the-art MD simulations reveals an emerging model
of Ca2þ sensitivity in the mammalian adult cardiac myo-
cyte. The main new findings presented here are that four
evolutionary conserved mammalian-specific cTnI residues,
Q157, A164, E166, and H173, in concert, facilitate normal
contractility and relaxation properties in the mammalian
adult heart. These four evolutionarily coordinated changes
in TnI residues establish an important biophysical trade-
off: gaining relaxation performance at the expense of preser-
ving contractile vigor in ischemia.
In support of this model, free energy perturbation analysis
of stable TnI-TnC conformations in MD simulations indi-
cates that TnI’s Helix 4 conformation and interaction with
cTnC is a key determinate of contractility and the basis
for the difference in cTnI function compared to ssTnI. We
propose salt bridge formation between H164 of cTnI and
E19 of cTnC and R171 of cTnI and E15 of cTnC initiates
an intramolecular conformation change in cTnC to cause
increased Ca2þ binding affinity as revealed by cTnI
QAEH. This leads to a model prediction of increased TnI-
cTnC interaction leading to increased contractility and
slowed relaxation because of ssTnI substitutions Q157R/
A164H/E166V/H173N in cTnI. By this deeper understand-
ing of TnI-TnC interactions a strong foundation is estab-
lished to instruct potential gene, protein, and small
molecule therapeutics in heart disease.
In Fig. 8, we present a synthesis of key isoform-specific
TnI residues that impact structure and function based onAcidic pH
Delta pH 
change
++ + ++ ++ +
Relaxation 
time
Structure N.D.
H164-E19 
interaction
Helix 4 
interaction
-
- -
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FIGURE 8 Summary of isoform-specific residues as molecular determi-
nants of TnI function. Compilation of functional data depicting neutral pH
and acidic pH contractility, the change in contractility from neutral pH to
acidic pH (Delta pH change) and relaxation time at neutral pH.4 indicates
no change in contractility/relaxation time compared to cTnI neutral pH, [
indicates increased contractility/relaxation time compared to cTnI, Y indi-
cates decreased contractility with acidosis, þ indicates small change in
contractility from neutral pH to acidic pH, þþ indicates marked change
in contractility from neutral pH to acidic pH. Sequence of the isoform-
specific residues with black residues from cTnI and green residues from
ssTnI. Atomistic stick figure showing cTnC helix A (red) in relation to
cTnI switch peptide and helix 4 (blue) from MD simulations. N.D. (not
determined). To see this figure in color, go online.
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results (11,19). At neutral pH, cTnI and cTnI A164H have
similar contractility. whereas ssTnI, cTnI QAEH, and cTnI
AH have increased contractility. In acidosis, cTnI has
decreased contractility, whereas all the other constructs
maintain normal contractility. The change in contractility
from neutral pH to acidic pH (delta pH change) shows
that cTnI, cTnI QAEH, and cTnI AH have marked contrac-
tility changes, whereas ssTnI and cTnI A164H have
comparatively small contractility changes. Relaxation time
shows cTnI and cTnI A164H have normal relaxation at
neutral pH, whereas ssTnI, cTnI QAEH, and cTnI AH
have increased relaxation times. The atomistic structure
depicting cTnC helix A in relation to cTnI switch peptide
and helix 4 models a 90 bend of TnI for ssTnI and cTnI
QAEH due to H164-E19 interaction and further interactions
of helix 4 with cTnC helix A, specifically R171-E15 for
cTnI QAEH. Furthermore, cTnI A164H has a slight bend
in TnI, due to H164-E19 interaction but no further interac-
tions of helix 4 with cTnC helix A. MD simulations were
not performed for cTnI AH (N.D. for structure). The model
suggests that the bent conformation with H164-E19 interac-
tion seen in ssTnI, cTnI A164H, and cTnI QAEH maintains
contractility in acidosis, although further interactions of TnI
helix 4 with cTnC Helix A as for ssTnI and cTnI QAEH
results in increased contractility and relaxation time at
neutral pH. Taken as a whole, cTnIs QAEH and AH struc-
turally and functionally mimic ssTnI, suggesting that these
evolutionary conserved residues are necessary for normal
mammalian heart function.
Studies comparing cTnI protein sequences across species
reveal that in chordate evolution at the mammalian diver-
gence there was a key histidine to alanine transition at posi-
tion 164 (numbering corresponding to rodent cTnI) (11). All
non-mammalian chordate cTnIs have a histidine at this po-
sition and resemble ssTnI in sequence. At this same evolu-
tionary divergence point, three other amino acids in this
same region of cTnI also transitioned in concert: R157Q,
V166E, and N173H. Thus, all mammalian cTnIs studied
to date have residues Q157, A164, E166, and H173. These
changes result in an overall potential charge difference of
negative two, if you protonate the histidines. We previously
speculated (19) that this could alter the conformation and/or
interaction of cTnI with cTnC to alter function of mamma-
lian cTnI. Indeed, Dargis et al. (16) showed that substitu-
tions of Q157R/A164H/E166V in cTnI increased Ca2þ
sensitivity in thin filament ATPase assays. They also showed
that cTnI H164 is necessary for this effect. Our findings in
intact myocytes show that cTnI Q157R/A164H/E166V/
H173N (QAEH) increases contractility and slows relaxation
under physiologic pH conditions, functionally mimicking
ssTnI. MD simulations show that cTnI QAEH HSP helix
4 bends and has multiple contacts with helix A of cTnC
that structurally mimic sTnI. Taken together, these data
are evidence that cTnI isoform-specific residues Q157,Biophysical Journal 106(10) 2105–2114A164, E166, and H173 are required to maintain normal
contractile function in the adult cardiac myocyte. Further-
more, cTnI A164H/H173N (AH) functionally mimics ssTnI
at pH 7.4, suggesting that this second histidine (H173) is
sufficient for maintaining normal contractile function under
neutral pH conditions in A164H cTnI. Previous investiga-
tion of ssTnI N141H (the cTnI substitution in ssTnI) showed
this improves relaxation of adult cardiac myocytes
compared to ssTnI while still maintaining Ca2þ sensitivity
in acidosis (12). Together these two pieces of evidence indi-
cate that two histidines (H164 and H173) are necessary for
maintaining normal contractility at neutral pH while preser-
ving function at acidic pH. Structurally, H173 does not
interact directly with cTnC, but when present, as in
A164H MD simulations from Palpant et al. (19), the
R171-E15 salt bridge is not observed. This second histidine
may alter helix 4 conformation when protonated, disrupting
the R171-E15 salt bridge. Further investigation of the role of
H173 structurally is necessary to clarify this point. Con-
struction of a fish-like cTnI (AH) in these four residues
suggests that fish cTnI is relatively Ca2þ sensitive and pH
resistant. Previously, trout cTnI was shown to increase
Ca2þ binding affinity in the context of mammalian cTnC
compared to mammalian cTnI (42). Our data suggest that
cTnI helix 4 residue differences may contribute to the
increased Ca2þ sensitivity of trout. The requirement for
decreased Ca2þ sensitivity in the heart of endotherms has
been proposed (11) and is supported by our results that
sequence divergence at the mammalian lineage results in
negative inotropy with enhanced relaxation performance.
MD simulations shown here support a mechanism of
increased TnI-cTnC interaction following switch peptide
binding to cTnC, thus increasing affinity of TnI to TnC. Spe-
cifically, MD simulations reveal a new potential TnI-TnC
interaction, cTnI R171-cTnC E15, that is critical to further
enhance function. R171 is highly conserved throughout
TnI evolution and a human mutation, R170Q (human
numbering) has been implicated as a cause of preadolescent
HCM suggesting its position is susceptible to alter troponin
function (11,43). Increasing or decreasing affinity of TnI to
cTnC has been proposed to be part of the mechanism of
small molecule Ca2þ sensitizers and desensitizers respec-
tively (44). Recent NMR data suggest that increased affinity
is how sTnI maintains contractile function under acidic con-
ditions through H132-E19 interaction (17). The increased
interaction in cTnI QAEH HSP R171 with cTnC E15 corre-
lates with a more negative free energy of Ca2þ binding sup-
porting that this conformation increases Ca2þ sensitivity
relative to WT cTnI. These simulations and FEP calcula-
tions further corroborate the cTnI H164-cTnC E19 salt
bridge as being the mechanism of increased Ca2þ sensitivity
in acidosis of natural and genetically engineered histidine
containing TnIs. The FEP analysis of cTnI A164H from
Palpant et al. (19) shows a strong correlation to the cellular
physiologic data presented here. There is no change in free
Troponin I and Myocyte Relaxation 2113energy of Ca2þ binding in the deprotonated cTnI A164H
mimicking the pH 7.4 cellular data showing no statistical
change in contractility measures. Furthermore, the proton-
ated form shows a more negative free energy of Ca2þ
binding mimicking the pH 6.2 cellular data of maintained
contractility. Interestingly, the FEP data show that the de-
protonated form of cTnI QAEH has lower free energy of
Ca2þ binding than cTnI. Again, this correlates with the
cellular dynamics data where this substitution has increased
contractility and slowed relaxation at physiologic pH 7.4.
These correlations between cellular contractility and FEP
analysis of cTnC simulations are evidence that FEP analysis
is a valuable tool to understand structural implications to
Ca2þ binding in cTnC.
The cTnI QAEH HSD simulations generally look similar
to cTnI. Analysis of pKa measures show a difference of
cTnC salt bridges between E40-K39 in cTnC, whereas in
cTnI QAEH HSD and HSP, as well as sTnI, cTnC E40
interacted more closely with cTnC K43. This was corrobo-
rated through distance measurements over the entire 40 ns
simulations. E40 of cTnC is the 12th residue of the inactive
site I Ca2þ binding loop. Mutation of this residue to alanine
shows Ca2þ desensitization of thin filament force produc-
tion and has been shown to alter the closed to open transition
of the hydrophobic patch in the Ca2þ bound state through
MD simulation (45,46). Other Ca2þ sensitizing/desensitiz-
ing modifications in TnC helix C result in alterations of
cTnC site I and are proposed to influence Ca2þ binding to
site II (40,41). Based on these findings, we speculate that
the altered salt bridge in cTnI QAEH HSD, cTnC E40-
K39 to E40-K43, plays a key role in the decreased free en-
ergy of Ca2þ binding shown here.
Free energy perturbation analysis of the Ca2þ bound
structures presented here also suggests that the switch
peptide/helix 4 interactions of cTnI QAEH with cTnC deter-
mine, at least a portion of the Ca2þ sensitivity seen in
cardiac myocytes. The FEP analysis only accounts for
the TnI and Ca2þ bound cTnC state, therefore cTnI
QAEH increases Ca2þ affinity in this state, which would
result in a slower off-rate of Ca2þ. A slower Ca2þ off-rate
correlates with the slow relaxation shown here in cTnI
QAEH expressing cardiac myocytes. In total, the FEP
analysis is evidence that cTnI A164H and cTnI QAEH alter
cellular function by increasing interactions between cTnI
helix 4 and cTnC helix A.
An alternate explanation of how these TnI-TnC confor-
mations give rise to altered Ca2þ sensitivity could be
through direct or indirect tropomyosin/actin interaction.
Directly, these substitutions are not involved in actin inter-
action but they are very close to the second actin binding
motif in TnI. Thus, indirectly, the bent TnI conformation
may position TnI’s mobile domain and second actin binding
motif in a position that favors contraction rather than relax-
ation. Further structure/function studies are necessary to
investigate this possibility.In conclusion, this study provides, to our knowledge, new
mechanistic insights into TnI-TnC interactions that under-
score molecular inotropy and relaxation. We propose that
cTnI residues Q157, A164, E166, and H173, in concert,
facilitate mammalian cardiac myocyte-enhanced relaxation
and thus essential for normal heart function in eutherians.
Our results also extend to troponin action itself, defining a
model of cTnI helix 4 conformation and interaction with
cTnC as being a key determinate of cardiac myocyte relax-
ation performance. This work enhances our knowledge of
the mechanisms of Ca2þ sensitivity and further establishes
a foundation to aid in the design of new therapeutics target-
ing TnI-TnC interaction in diseases of the sarcomere, such
as hypertrophic and ischemic cardiomyopathy.SUPPORTING MATERIAL
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